Eyegene | Biotech & Life Sciences

01Company Overview

EYEGENE Inc. is a biotechnology company dedicated to developing innovative biopharmaceuticals, vaccines, and diagnostic systems for the treatment and prevention of age-related diseases. The company utilizes platform technologies such as immune adjuvants and is actively involved in research and development of vaccines for diseases like diabetic retinopathy, herpes zoster, COVID-19, and others.

02Backed By1 investor

KIKorea Investment Partners→

03Similar Companies